Marion Wilson, MD
Ophthalmology · Charleston, SCNPI 1124030515
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $7,035 of the $9,290 with a category attached, or 75.7%. Alcon Research LLC accounts for 64.4% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2021 at $7,201 and has fallen 96.0% since, to $286 in 2025.
Across 27 payments — averaging $344.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon Research LLC$6K
- Kala Pharmaceuticals, Inc.$1K
- AbbVie$371
- Alcon$276
- Bausch & Lomb, A Division Of Bausch Health US, LLC$249
- Bausch & Lomb Americas Inc.$241
- plus $1K from 11 others
Across 20 payments — averaging $4051.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ocular Therapeutix, Inc.$60K
- Eyepoint US, Inc.$17K
- Ophtec USA, Inc.$4K
What the payments were for
- Consulting fees$7,03576%
- Food & beverage$2,25524%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon Research LLC | 1 | $5,985 |
| Kala Pharmaceuticals, Inc. | 1 | $1,050 |
| AbbVie(2 entities) | 4 | $371 |
| Alcon | 2 | $276 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $249 |
| Bausch & Lomb Americas Inc. | 2 | $241 |
| Omeros Corporation | 3 | $237 |
| Amgen | 1 | $168 |
| Genentech, Inc. | 1 | $137 |
| Novartis | 1 | $124 |
| Ocular Therapeutix, Inc. | 1 | $113 |
| Aerie Pharmaceuticals, Inc. | 1 | $106 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $99 |
| Eyepoint US, Inc. | 1 | $71 |
| Mallinckrodt Hospital Products Inc. | 1 | $28 |
| Biotissue Holdings Inc. | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,290 in reported general payments places this provider in the 85th percentile of 293 ophthalmology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Charleston
- Karolinne RochaCharleston$552K
- Drew DicksonCharleston$53K
- Mona CamacciCharleston$26K
- Cole MillikenCharleston$17K
- Daniel AlfaroCharleston$15K
- Karen FernandezCharleston$13K
- John KerrisonCharleston$12K
- Eric JablonCharleston$12K
- Michael JohnsonCharleston$9K
- Berdine BurgerCharleston$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.